Bispecific antibody affords complete post-exposure protection of mice from both Ebola (Zaire) and Sudan viruses

Julia C. Frei, Elisabeth K. Nyakatura, Samantha E. Zak, Russell R. Bakken, Kartik Chandran, John M. Dye, Jonathan R. Lai

Research output: Contribution to journalArticle

15 Scopus citations

Abstract

Filoviruses (Ebola and Marburg) cause severe hemorrhagic fever. There are five species of ebolavirus; among these, the Ebola (Zaire) and Sudan viruses (EBOV and SUDV, respectively) are highly pathogenic and have both caused recurring, large outbreaks. However, the EBOV and SUDV glycoprotein (GP) sequences are 45% divergent and thus antigenically distinct. Few antibodies with cross-neutralizing properties have been described to date. We used antibody engineering to develop novel bispecific antibodies (Bis-mAbs) that are cross-reactive toward base epitopes on GP from EBOV and SUDV. These Bis-mAbs exhibit potent neutralization against EBOV and SUDV GP pseudotyped viruses as well as authentic pathogens, and confer a high degree (in one case 100%) post-exposure protection of mice from both viruses. Our studies show that a single agent that targets the GP base epitopes is sufficient for protection in mice; such agents could be included in panfilovirus therapeutic antibody cocktails.

Original languageEnglish (US)
Article number19193
JournalScientific Reports
Volume6
DOIs
StatePublished - Jan 13 2016

    Fingerprint

ASJC Scopus subject areas

  • General

Cite this